Guggenhime Andrew: insider trades.
Guggenhime Andrew reported 9 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.1M), across 1 company.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- GUGGENHIME ANDREW
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Vaxcyte, Inc. (PCVX) | Officer · PRESIDENT AND CFO | 9 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Vaxcyte, Inc. | F | 7,155 | $60.36 | 95,316 | Form 4 |
| 2026-09-02 | Vaxcyte, Inc. | F | 1,432 | $61.58 | 102,471 | Form 4 |
| 2026-08-31 | Vaxcyte, Inc. | F | 1,273 | $60.74 | 103,903 | Form 4 |
| 2026-08-03 | Vaxcyte, Inc. | S | 6,956 | $53.76 | 108,220 | Form 4 |
| 2026-08-03 | Vaxcyte, Inc. | M | 10,000 | $5.35 | 115,176 | Form 4 |
| 2026-08-03 | Vaxcyte, Inc. | S | 3,044 | $54.18 | 105,176 | Form 4 |
| 2026-07-06 | Vaxcyte, Inc. | M | 10,000 | $5.35 | 114,395 | Form 4 |
| 2026-07-06 | Vaxcyte, Inc. | S | 2,087 | $57.76 | 104,395 | Form 4 |
| 2026-07-06 | Vaxcyte, Inc. | S | 7,913 | $57.16 | 106,482 | Form 4 |
Questions
What stock did Guggenhime Andrew buy or sell?
Guggenhime Andrew reported 9 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.1M), across 1 company.
Is Guggenhime Andrew the same person as other filers with this name?
This page covers SEC CIK 1230724 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/guggenhime-andrew-1230724.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.